CN Stock MarketDetailed Quotes
688298 Zhejiang Orient Gene Biotech
- 31.24
- -0.86-2.68%
Market Closed Dec 13 15:00 CST
6.30BMarket Cap-10.72P/E (TTM)
32.04High31.19Low26.95KlotVolume32.03Open32.10Pre Close84.59MTurnover1.34%Turnover RatioLossP/E (Static)201.60MShares41.4952wk High0.92P/B6.30BFloat Cap24.4052wk Low38.52Limit Up201.60MShs Float239.66Historical High25.68Limit Down2.65%Amplitude24.40Historical Low--Dividend TTM31.39Avg Price17.58KlotAsk--Div YieldTTM100Lot Size8.65KlotBid
Zhejiang Orient Gene Biotech Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 58.37%630.25M | 61.98%374.4M | 99.69%169.93M | -94.43%574.19M | -95.61%397.97M | -97.06%231.14M | -98.12%85.1M | 9.74%10.31B | 24.83%9.06B | 110.40%7.87B |
| Refunds of taxes and levies | -73.27%40.3M | -80.74%24.59M | -25.19%14.95M | -25.14%238.23M | -44.94%150.74M | -76.16%127.68M | -82.70%19.98M | -16.55%318.24M | 37.78%273.76M | 314.55%535.45M |
| Cash received relating to other operating activities | -44.54%99.59M | -46.70%78.74M | -66.31%43.84M | 53.68%265.17M | 50.47%179.56M | 118.42%147.75M | -30.29%130.13M | 151.48%172.55M | -46.74%119.34M | -20.34%67.64M |
| Cash inflows from operating activities | 5.75%770.13M | -5.69%477.74M | -2.76%228.72M | -90.02%1.08B | -92.30%728.27M | -94.02%506.56M | -95.13%235.21M | 9.71%10.8B | 23.08%9.45B | 114.26%8.47B |
| Goods services cash paid | -67.68%444M | -62.90%318.73M | -54.51%190.85M | -62.14%1.49B | -63.54%1.37B | -74.41%859.16M | -76.06%419.5M | 110.93%3.93B | 168.46%3.77B | 351.36%3.36B |
| Staff behalf paid | -24.19%386.81M | -34.39%264.43M | -52.11%144.28M | -56.47%614.6M | -60.03%510.21M | -64.07%403.06M | -45.98%301.25M | 96.74%1.41B | 173.06%1.28B | 247.34%1.12B |
| All taxes paid | -82.55%36.2M | -85.84%28.68M | -79.83%20.85M | -85.04%213.92M | -85.84%207.45M | -74.03%202.51M | -35.49%103.38M | 122.99%1.43B | 158.50%1.47B | 105.94%779.87M |
| Cash paid relating to other operating activities | 5.36%270.28M | -13.37%198.27M | -40.69%84.61M | -60.53%407.99M | -75.45%256.54M | -74.05%228.87M | -75.81%142.64M | -27.10%1.03B | 0.01%1.05B | 6.97%881.83M |
| Cash outflows from operating activities | -51.56%1.14B | -52.17%810.11M | -54.43%440.58M | -65.10%2.72B | -68.92%2.35B | -72.42%1.69B | -68.40%966.77M | 68.21%7.8B | 116.91%7.55B | 170.55%6.14B |
| Net cash flows from operating activities | 77.33%-367.15M | 72.00%-332.37M | 71.04%-211.86M | -154.93%-1.65B | -185.32%-1.62B | -150.88%-1.19B | -141.24%-731.56M | -42.43%3B | -54.77%1.9B | 38.44%2.33B |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 0.65%471.8M | -10.86%317.97M | 152.34%532.45M | -16.73%552.58M | -43.29%468.76M | -42.88%356.72M | 94.23%211M | -62.11%663.61M | -32.19%826.55M | -33.55%624.55M |
| Cash received from returns on investments | -11.82%48.39M | 20.05%26.25M | -39.26%6.62M | 188.63%43.51M | 2,163.94%54.88M | 2,650.98%21.87M | 2,137.43%10.89M | --15.08M | -60.81%2.42M | -78.64%794.87K |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 168.01%76.65K | --21.2K | --20.8K | -68.49%814.44K | -98.36%28.6K | ---- | ---- | 44.64%2.58M | 82.07%1.74M | -96.48%33.63K |
| Cash received relating to other investing activities | 19,922.33%2.84B | --1.27B | ---- | 316.53%63.4M | --14.2M | ---- | --2.3M | --15.22M | --0 | ---- |
| Cash inflows from investing activities | 525.33%3.36B | 326.69%1.62B | 140.45%539.08M | -5.19%660.31M | -35.25%537.86M | -39.46%378.58M | 105.46%224.2M | -60.27%696.49M | -32.25%830.71M | -33.79%625.38M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -6.89%501.66M | -6.40%383.8M | 0.66%243.92M | -5.31%996.05M | 0.42%538.79M | -1.66%410.04M | -6.01%242.32M | 107.13%1.05B | 74.17%536.57M | 83.76%416.99M |
| Cash paid to acquire investments | 42.08%224.03M | 109.20%123M | 833.98%352.07M | -72.93%471.05M | -80.74%157.68M | -90.99%58.8M | -89.70%37.7M | 14.23%1.74B | -47.85%818.53M | -31.41%652.68M |
| Net cash paid to acquire subsidiaries and other business units | 432.71%322.41M | 432.71%322.41M | --43.82M | -57.53%78.52M | -64.60%60.52M | -30.23%60.52M | ---- | 323.00%184.87M | 344.58%170.98M | --86.75M |
| Cash paid relating to other investing activities | 95,754.98%2.57B | 61,345.16%1.65B | ---- | 1,190.23%1.23B | --2.68M | --2.68M | --1M | --95.52M | --0 | ---- |
| Cash outflows from investing activities | 376.13%3.62B | 365.37%2.48B | 127.68%639.82M | -9.57%2.78B | -50.22%759.68M | -53.99%532.04M | -54.94%281.02M | 48.08%3.07B | -20.36%1.53B | -1.87%1.16B |
| Net cash flows from investing activities | -14.32%-253.58M | -460.78%-860.58M | -77.29%-100.73M | 10.86%-2.12B | 68.10%-221.81M | 71.10%-153.46M | 88.96%-56.82M | -638.63%-2.38B | -0.77%-695.37M | -127.05%-531.03M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | --360K | --360K | --360K | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | --360K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from borrowing | -58.53%290.7M | -63.06%184.7M | -78.88%105.6M | 1,444.00%772M | 1,302.00%701M | --500M | --500M | --50M | --50M | ---- |
| Cash received relating to other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Cash inflows from financing activities | -58.48%291.06M | -62.99%185.06M | -78.81%105.96M | 1,444.00%772M | 1,302.00%701M | --500M | --500M | 1,924.29%50M | 1,924.29%50M | ---- |
| Borrowing repayment | 30.76%351.6M | 185.97%197M | --126M | --318.5M | --268.89M | --68.89M | --0 | --0 | --0 | ---- |
| Dividend interest payment | -97.20%10.94M | -97.82%7.43M | 126.54%4.04M | -49.68%373.41M | -47.35%390.64M | -54.11%340.3M | --1.78M | 47.03%742.04M | 47.20%741.91M | --741.6M |
| -Including:Cash payments for dividends or profit to minority shareholders | ---- | ---- | ---- | --22.27M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash payments relating to other financing activities | 4,836.66%303.51M | 5,484.53%289.06M | --5.95M | 391.95%30.56M | -93.40%6.15M | -89.77%5.18M | ---- | -10.90%6.21M | 1,625.58%93.12M | 1,350.56%50.61M |
| Cash outflows from financing activities | 0.06%666.05M | 19.10%493.49M | 7,523.33%135.99M | -3.45%722.46M | -20.28%665.68M | -47.70%414.36M | --1.78M | 46.24%748.25M | 63.92%835.02M | 22,605.68%792.21M |
| Net cash flows from financing activities | -1,161.60%-374.99M | -460.15%-308.43M | -106.03%-30.03M | 107.09%49.54M | 104.50%35.32M | 110.81%85.64M | --498.22M | -37.13%-698.25M | -54.86%-785.02M | -39,136.96%-792.21M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -89.54%9.89M | -74.49%33.61M | 125.03%9.31M | -84.00%85.85M | -83.31%94.54M | 504.83%131.79M | -53.71%-37.21M | 811.36%536.65M | 4,394.07%566.6M | 156.50%21.79M |
| Net increase in cash and cash equivalents | 42.40%-985.83M | -30.69%-1.47B | -1.81%-333.31M | -891.06%-3.63B | -273.85%-1.71B | -208.86%-1.12B | -126.50%-327.38M | -89.33%458.62M | -67.04%984.54M | -26.87%1.03B |
| Add:Begin period cash and cash equivalents | -55.33%2.93B | -55.33%2.93B | -55.33%2.93B | 7.52%6.56B | 7.52%6.56B | 7.52%6.56B | 7.52%6.56B | 238.71%6.1B | 238.71%6.1B | 238.71%6.1B |
| End period cash equivalent | -59.90%1.94B | -73.11%1.46B | -58.34%2.6B | -55.33%2.93B | -31.59%4.84B | -23.79%5.43B | -15.06%6.23B | 7.52%6.56B | 47.93%7.08B | 122.03%7.13B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
